Leerink Swann Initiates ACADIA Pharmaceuticals At Outperform


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Analysts at Leerink Swann initiated coverage on

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) with a Outperform rating.The target price for ACADIA Pharmaceuticals is set to $48.ACADIA Pharmaceuticals shares have gained 92.90% over the past 52 weeks, while the S&P 500 index has surged 12.97% in the same period.ACADIA Pharmaceuticals shares rose 1.33% to $38.00 in pre-market trading.
Posted In: InitiationAnalyst RatingsLeerink Swann